Kessler Promises Cancer Patient Liaison In FDA; Considers Joint Drugs, Biologics Oncology Review
In Brief: Painter Is AMA President-Elect; FDA Approves Taxol; Protocol Enrolls 150-200 A Month
FDA’s Commitment To Cancer No Different Than Other Diseases, Kessler Tells Advocate
FDA Officials Lists ‘Lessons’ Learned Working With AIDS Patient Organizations
FDA Lacks Resources To Deal With Onslaught Of New Cancer Drugs, Friedman Tells Agency
Trending Stories
- Rick and Mary Pazdur on facing “the other side of the stethoscope”
A few months before Mary died of ovarian cancer, the couple shared how this experience shaped their perspectives on oncology - She flew Black Hawks and battled cancer—now Col. Susan Fondy grapples with cuts to lymphedema research
- Imaging’s ride to the bottom in clinical trials—and why it matters now
- HHS seems poised to exert control over USPSTF
Ransohoff: The task force is the pinnacle of evidence-based medicine - The Directors: Mark Evers and Steven Libutti on riding out the tempest—and maintaining research momentum
As oncology braces for funding, Medicaid cuts, these two directors tell young investigators not to panic - First-ever financial toxicity tumor board aims to change the standard of care
Researchers focus on debt as a side effect of cancer, treatment amid cuts to Medicaid, NCI
